Free Trial

CME Group (CME) Stock Forecast & Price Target

CME Group logo
$259.83 +1.00 (+0.39%)
Closing price 04:00 PM Eastern
Extended Trading
$259.86 +0.03 (+0.01%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CME Group - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
3
Hold
9
Buy
4

Based on 16 Wall Street analysts who have issued ratings for CME Group in the last 12 months, the stock has a consensus rating of "Hold." Out of the 16 analysts, 3 have given a sell rating, 9 have given a hold rating, and 4 have given a buy rating for CME.

Consensus Price Target

$260.60
0.30% Upside
According to the 16 analysts' twelve-month price targets for CME Group, the average price target is $260.60. The highest price target for CME is $304.00, while the lowest price target for CME is $198.00. The average price target represents a forecasted upside of 0.30% from the current price of $259.83.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CME and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for CME Group and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CME Analyst Ratings Over Time

TypeCurrent Forecast
9/16/24 to 9/16/25
1 Month Ago
8/17/24 to 8/17/25
3 Months Ago
6/18/24 to 6/18/25
1 Year Ago
9/17/23 to 9/16/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
5 Buy rating(s)
3 Buy rating(s)
Hold
9 Hold rating(s)
9 Hold rating(s)
8 Hold rating(s)
4 Hold rating(s)
Sell
3 Sell rating(s)
3 Sell rating(s)
3 Sell rating(s)
4 Sell rating(s)
Consensus Price Target$260.60$261.93$258.20$209.73
Forecasted Upside0.30% Upside-4.38% Downside-5.11% Downside-4.03% Downside
Consensus RatingHoldHoldHoldReduce

CME Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CME Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CME Group Stock vs. The Competition

TypeCME GroupFinance CompaniesS&P 500
Consensus Rating Score
2.06
2.52
2.53
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside-0.26% Downside18.89% Upside11.67% Upside
News Sentiment Rating
Positive News

See Recent CME News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
9/8/2025UBS Group
4 of 5 stars
Alex Kramm
Alex Kramm
Not Rated
Lower TargetNeutral$305.00 ➝ $285.00+8.80%
7/24/2025Oppenheimer
2 of 5 stars
Owen Lau
Owen Lau
2 of 5 stars
Boost TargetOutperform$300.00 ➝ $303.00+9.30%
7/24/2025Barclays
3 of 5 stars
Benjamin Budish
Benjamin Budish
Not Rated
Set TargetEqual Weight$299.00 ➝ $298.00+7.78%
7/15/2025Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$283.00 ➝ $296.00+8.10%
7/3/2025Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetNeutral$265.00 ➝ $275.00+0.09%
5/24/2025Erste Group Bank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyHold
4/24/2025Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$301.00 ➝ $304.00+14.70%
4/24/2025Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetMarket Perform$265.00 ➝ $273.00+2.83%
4/24/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetUnderweight$223.00 ➝ $211.00-20.48%
4/3/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSector Perform$269.00 ➝ $269.00-0.64%
4/2/2025Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetUnderperform$200.00 ➝ $219.00-16.64%
3/10/2025Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeMarket PerformOutperform$287.00+12.74%
11/11/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetHold$227.00 ➝ $226.00-0.14%
10/8/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuyNeutral$244.00+10.04%
10/3/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetSell$195.00 ➝ $198.00-11.89%
9/26/2024TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageHold$221.00+1.60%
4/25/2024Rosenblatt Securities
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingSell$185.00 ➝ $187.00-12.04%
3/6/2024Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$225.00 ➝ $245.00+12.27%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 11:01 PM ET.


Should I Buy CME Group Stock? CME Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, September 15, 2025. Please send any questions or comments about these CME Group pros and cons to contact@marketbeat.com.

CME Group
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in CME Group Inc.:

  • The current stock price is around $260, which may present a buying opportunity for investors looking for value in the financial services sector.
  • CME Group Inc. reported a strong quarterly earnings performance, with earnings per share exceeding expectations, indicating robust financial health and operational efficiency.
  • The company has a high net margin, suggesting that it retains a significant portion of revenue as profit, which can be attractive for investors seeking stable returns.
  • Recent analyst upgrades and positive price target adjustments reflect growing confidence in CME Group Inc.'s future performance, which can lead to potential stock price appreciation.
  • The firm has a consistent dividend payout, with a recent quarterly dividend of $1.25 per share, providing income to investors and demonstrating a commitment to returning value to shareholders.

CME Group
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in CME Group Inc. for these reasons:

  • The stock has experienced a recent decline of about 0.8%, which may indicate short-term volatility and uncertainty in the market.
  • Despite strong earnings, the price-to-earnings ratio is relatively high, suggesting that the stock may be overvalued compared to its earnings, which could deter value-focused investors.
  • Analysts have mixed ratings, with some firms downgrading their price targets, indicating potential concerns about future growth prospects.
  • The company operates in a competitive financial services environment, which can pose risks to market share and profitability.
  • With a significant portion of shares owned by institutional investors, retail investors may have less influence on stock performance and decision-making, which could be a concern for individual investors.

CME Forecast - Frequently Asked Questions

According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for CME Group is $260.60, with a high forecast of $304.00 and a low forecast of $198.00.

16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 3 sell ratings, 9 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CME shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CME, but not buy additional shares or sell existing shares.

According to analysts, CME Group's stock has a predicted upside of 0.30% based on their 12-month stock forecasts.

CME Group has been rated by research analysts at Barclays, Citigroup, Oppenheimer, Piper Sandler, and UBS Group in the past 90 days.

Analysts like CME Group less than other "finance" companies. The consensus rating for CME Group is Hold while the average consensus rating for "finance" companies is Moderate Buy. Learn more on how CME compares to other companies.


This page (NASDAQ:CME) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners